Dacarbazine- or Temozolomide-Based Chemotherapy in Metastatic Digestive Neuroendocrine Carcinomas in Post First-line Chemotherapy: A Retrospective Multicentric Study of the French Group of Endocrine Tumours (GTE) - Archive ouverte HAL Accéder directement au contenu
Communication Dans Un Congrès Année : 2020

Dacarbazine- or Temozolomide-Based Chemotherapy in Metastatic Digestive Neuroendocrine Carcinomas in Post First-line Chemotherapy: A Retrospective Multicentric Study of the French Group of Endocrine Tumours (GTE)

Fichier non déposé

Dates et versions

hal-04493659 , version 1 (07-03-2024)

Licence

Paternité - Pas d'utilisation commerciale - Pas de modification

Identifiants

  • HAL Id : hal-04493659 , version 1

Citer

Thomas Walter. Dacarbazine- or Temozolomide-Based Chemotherapy in Metastatic Digestive Neuroendocrine Carcinomas in Post First-line Chemotherapy: A Retrospective Multicentric Study of the French Group of Endocrine Tumours (GTE). 17th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2020, Virtual conference, Germany. pp.(H08). ⟨hal-04493659⟩
2 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More